Standard BioTools
LAB
89 hedge funds and large institutions have $510M invested in Standard BioTools in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
48% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 25
32% more call options, than puts
Call options by funds: $1.18M | Put options by funds: $899K
31% more capital invested
Capital invested by funds: $389M → $510M (+$120M)
11% more funds holding
Funds holding: 80 → 89 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$13.8M |
| 2 |
PC
Pier Capital
Stamford,
Connecticut
|
+$6.78M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$6.72M |
| 4 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$5.13M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$6.04M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.41M |
| 3 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$4.21M |
| 4 |
Jennison Associates
New York
|
-$4M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.66M |
LAB Hedge Fund Activity: Q3 2013 in Review
89 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2013, worth a combined $510M — up 31% from $389M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new LAB positions and 7 closed out — a net gain of 9 holders — while 37 added to existing stakes and 25 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $13.8M. The largest seller was Fort Washington Investment Advisors, cutting an estimated $6.04M.
- 89 institutional investors held Standard BioTools (LAB) as of Q3 2013, up from 80 in Q2 2013.
- Funds reported $510M of Standard BioTools stock for Q3 2013, up 31% quarter-over-quarter.
- 16 funds opened new Standard BioTools positions in Q3 2013 and 7 closed out, a net change of +9 holders.
- The largest Standard BioTools buyer in Q3 2013 was Lord, Abbett & Co, an estimated $13.8M added.
- The largest Standard BioTools seller in Q3 2013 was Fort Washington Investment Advisors, an estimated $6.04M sold.
Based on aggregated 13F filings for Q3 2013.